{"id":13147,"date":"2021-09-30T14:09:00","date_gmt":"2021-09-30T05:09:00","guid":{"rendered":"https:\/\/microncro.com\/?p=13147"},"modified":"2026-05-18T16:16:10","modified_gmt":"2026-05-18T07:16:10","slug":"video_cde_fda","status":"publish","type":"post","link":"https:\/\/microncro.com\/en\/archives\/post\/video_cde_fda\/","title":{"rendered":"Video:Comparison of the CDE Guidance and the FDA Guidance"},"content":{"rendered":"\n<p class=\"is-small-size\">In recent years, there has been a noticeable increase in clinical trials of anticancer drugs in China.<br>Specifically, imaging endpoints derived from medical imaging assessments as surrogate endpoints are being chosen for more clinical trials.<br>In January 2021, the Centre for Drug Evaluation of China, the CDE, published guidance for the imaging endpoint process, especially focusing on antitumor clinical trials.<br>In this video, we compare the content of the China\u2019s CDE guidance with Clinical Trial Imaging Endpoint Process Standards: Guidance for Industry, the U.S. FDA guidance. It will mainly provide an introduction of the similar considerations and differences between the two.<\/p>\n\n\n\n<p class=\"is-small-size\"><a href=\"https:\/\/microncro.com\/en\/resources\/video_cde_guidance_and_fda_guidance\/\">Video: Comparison of the CDE Guidance and the FDA Guidance for Antitumor Clinical Trials using Imaging Endpoints.<\/a><\/p>\n\n\n\n<p class=\"is-small-size\">Contacts<br>Micron, Inc.<br>E-mail\uff1aimagingbiomarker@micron-kobe.com<\/p>\n\n\n\n\n<div class=\"micron-share\">\n\t<div class=\"micron-share-inner\">\n\t\t<h2 class=\"micron-share-title\">Share<\/h2>\n\t\t<ul class=\"micron-share-buttons\">\n\t\t\t<li><a class=\"micron-share-button-linkedin\" href=\"https:\/\/www.linkedin.com\/sharing\/share-offsite\/?url=https:\/\/microncro.com\/en\/archives\/post\/video_cde_fda\/\" rel=\"nofollow\" target=\"_blank\">LinkedIn \u3067\u30b7\u30a7\u30a2\u3059\u308b<\/a><\/li>\n\t\t<\/ul>\n\t<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>In recent years, there has been a noticeable increase in clinical trials of anticancer drugs in China.Specifically, imaging endpoints derived from medical imaging assessments as surrogate endpoints are being chosen for more clinical trials.In January 2021, the Centre for Drug Evaluation of China, the CDE, published guidance for the imaging endpoint process, especially focusing on [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_locale":"en_US","_original_post":"https:\/\/microncro.com\/?p=11600","footnotes":""},"categories":[31],"class_list":["post-13147","post","type-post","status-publish","format-standard","hentry","category-news","en-US"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Video:Comparison of the CDE Guidance and the FDA Guidance | Micron, Inc. | Molecular Imaging CRO Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/microncro.com\/en\/archives\/post\/video_cde_fda\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Video:Comparison of the CDE Guidance and the FDA Guidance | Micron, Inc. | Molecular Imaging CRO Network\" \/>\n<meta property=\"og:description\" content=\"In recent years, there has been a noticeable increase in clinical trials of anticancer drugs in China.Specifically, imaging endpoints derived from medical imaging assessments as surrogate endpoints are being chosen for more clinical trials.In January 2021, the Centre for Drug Evaluation of China, the CDE, published guidance for the imaging endpoint process, especially focusing on [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/microncro.com\/en\/archives\/post\/video_cde_fda\/\" \/>\n<meta property=\"og:site_name\" content=\"Micron, Inc.\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-30T05:09:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-18T07:16:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/OGP_W1200_H630.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"info@digitalcube.jp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"info@digitalcube.jp\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/video_cde_fda\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/video_cde_fda\\\/\"},\"author\":{\"name\":\"info@digitalcube.jp\",\"@id\":\"https:\\\/\\\/microncro.com\\\/#\\\/schema\\\/person\\\/122c381484536eeb18bd40a8b8e47aaf\"},\"headline\":\"Video:Comparison of the CDE Guidance and the FDA Guidance\",\"datePublished\":\"2021-09-30T05:09:00+00:00\",\"dateModified\":\"2026-05-18T07:16:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/video_cde_fda\\\/\"},\"wordCount\":135,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/video_cde_fda\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/video_cde_fda\\\/\",\"url\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/video_cde_fda\\\/\",\"name\":\"Video:Comparison of the CDE Guidance and the FDA Guidance | \u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3 | Molecular Imaging CRO Network\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/#website\"},\"datePublished\":\"2021-09-30T05:09:00+00:00\",\"dateModified\":\"2026-05-18T07:16:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/video_cde_fda\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/video_cde_fda\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/microncro.com\\\/en\\\/archives\\\/post\\\/video_cde_fda\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/microncro.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Video:Comparison of the CDE Guidance and the FDA Guidance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/microncro.com\\\/#website\",\"url\":\"https:\\\/\\\/microncro.com\\\/\",\"name\":\"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3\",\"description\":\"Molecular Imaging CRO Network\",\"publisher\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/microncro.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/microncro.com\\\/#organization\",\"name\":\"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3\",\"url\":\"https:\\\/\\\/microncro.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/microncro.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/microncro.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/OGP_W1200_H630.png\",\"contentUrl\":\"https:\\\/\\\/microncro.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/OGP_W1200_H630.png\",\"width\":1200,\"height\":630,\"caption\":\"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3\"},\"image\":{\"@id\":\"https:\\\/\\\/microncro.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/microncro.com\\\/#\\\/schema\\\/person\\\/122c381484536eeb18bd40a8b8e47aaf\",\"name\":\"info@digitalcube.jp\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7d5c326d6a3ad018af8e90e25c6d04791dd8bb4e2db179ff555b099914f501bd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7d5c326d6a3ad018af8e90e25c6d04791dd8bb4e2db179ff555b099914f501bd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7d5c326d6a3ad018af8e90e25c6d04791dd8bb4e2db179ff555b099914f501bd?s=96&d=mm&r=g\",\"caption\":\"info@digitalcube.jp\"},\"sameAs\":[\"https:\\\/\\\/microncro.com\"],\"url\":\"https:\\\/\\\/microncro.com\\\/archives\\\/post\\\/author\\\/infodigitalcube-jp\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Video:Comparison of the CDE Guidance and the FDA Guidance | Micron, Inc. | Molecular Imaging CRO Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/microncro.com\/en\/archives\/post\/video_cde_fda\/","og_locale":"en_US","og_type":"article","og_title":"Video:Comparison of the CDE Guidance and the FDA Guidance | Micron, Inc. | Molecular Imaging CRO Network","og_description":"In recent years, there has been a noticeable increase in clinical trials of anticancer drugs in China.Specifically, imaging endpoints derived from medical imaging assessments as surrogate endpoints are being chosen for more clinical trials.In January 2021, the Centre for Drug Evaluation of China, the CDE, published guidance for the imaging endpoint process, especially focusing on [&hellip;]","og_url":"https:\/\/microncro.com\/en\/archives\/post\/video_cde_fda\/","og_site_name":"Micron, Inc.","article_published_time":"2021-09-30T05:09:00+00:00","article_modified_time":"2026-05-18T07:16:10+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/OGP_W1200_H630.png","type":"image\/png"}],"author":"info@digitalcube.jp","twitter_card":"summary_large_image","twitter_misc":{"Written by":"info@digitalcube.jp","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/microncro.com\/en\/archives\/post\/video_cde_fda\/#article","isPartOf":{"@id":"https:\/\/microncro.com\/en\/archives\/post\/video_cde_fda\/"},"author":{"name":"info@digitalcube.jp","@id":"https:\/\/microncro.com\/#\/schema\/person\/122c381484536eeb18bd40a8b8e47aaf"},"headline":"Video:Comparison of the CDE Guidance and the FDA Guidance","datePublished":"2021-09-30T05:09:00+00:00","dateModified":"2026-05-18T07:16:10+00:00","mainEntityOfPage":{"@id":"https:\/\/microncro.com\/en\/archives\/post\/video_cde_fda\/"},"wordCount":135,"commentCount":0,"publisher":{"@id":"https:\/\/microncro.com\/#organization"},"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/microncro.com\/en\/archives\/post\/video_cde_fda\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/microncro.com\/en\/archives\/post\/video_cde_fda\/","url":"https:\/\/microncro.com\/en\/archives\/post\/video_cde_fda\/","name":"Video:Comparison of the CDE Guidance and the FDA Guidance | \u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3 | Molecular Imaging CRO Network","isPartOf":{"@id":"https:\/\/microncro.com\/#website"},"datePublished":"2021-09-30T05:09:00+00:00","dateModified":"2026-05-18T07:16:10+00:00","breadcrumb":{"@id":"https:\/\/microncro.com\/en\/archives\/post\/video_cde_fda\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/microncro.com\/en\/archives\/post\/video_cde_fda\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/microncro.com\/en\/archives\/post\/video_cde_fda\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/microncro.com\/en\/"},{"@type":"ListItem","position":2,"name":"Video:Comparison of the CDE Guidance and the FDA Guidance"}]},{"@type":"WebSite","@id":"https:\/\/microncro.com\/#website","url":"https:\/\/microncro.com\/","name":"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3","description":"Molecular Imaging CRO Network","publisher":{"@id":"https:\/\/microncro.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/microncro.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/microncro.com\/#organization","name":"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3","url":"https:\/\/microncro.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/microncro.com\/#\/schema\/logo\/image\/","url":"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/OGP_W1200_H630.png","contentUrl":"https:\/\/microncro.com\/wp-content\/uploads\/2026\/05\/OGP_W1200_H630.png","width":1200,"height":630,"caption":"\u682a\u5f0f\u4f1a\u793e\u30de\u30a4\u30af\u30ed\u30f3"},"image":{"@id":"https:\/\/microncro.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/microncro.com\/#\/schema\/person\/122c381484536eeb18bd40a8b8e47aaf","name":"info@digitalcube.jp","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7d5c326d6a3ad018af8e90e25c6d04791dd8bb4e2db179ff555b099914f501bd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7d5c326d6a3ad018af8e90e25c6d04791dd8bb4e2db179ff555b099914f501bd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7d5c326d6a3ad018af8e90e25c6d04791dd8bb4e2db179ff555b099914f501bd?s=96&d=mm&r=g","caption":"info@digitalcube.jp"},"sameAs":["https:\/\/microncro.com"],"url":"https:\/\/microncro.com\/archives\/post\/author\/infodigitalcube-jp\/"}]}},"_links":{"self":[{"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/posts\/13147","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/comments?post=13147"}],"version-history":[{"count":2,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/posts\/13147\/revisions"}],"predecessor-version":[{"id":13877,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/posts\/13147\/revisions\/13877"}],"wp:attachment":[{"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/media?parent=13147"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microncro.com\/wp-json\/wp\/v2\/categories?post=13147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}